Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INSULET CORPORATION

(PODD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
276.11(c) 278.27(c) 272.93(c) 281.6(c) 282.45(c) Last
426 081 639 158 382 827 360 312 516 158 Volume
+1.57% +0.78% -1.92% +3.18% +0.30% Change
More quotes
Financials (USD)
Sales 2021 1 084 M - -
Net income 2021 47,4 M - -
Net Debt 2021 228 M - -
P/E ratio 2021 387x
Yield 2021 -
Sales 2022 1 307 M - -
Net income 2022 102 M - -
Net Debt 2022 142 M - -
P/E ratio 2022 184x
Yield 2022 -
Capitalization 18 718 M 18 718 M -
EV / Sales 2021 17,5x
EV / Sales 2022 14,4x
Nbr of Employees 1 900
Free-Float 99,5%
More Financials
Company
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a... 
More about the company
Ratings of Insulet Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about INSULET CORPORATION
06/08INSULETá : Significant Insider Selling in Shares of Insulet (PODD) Continues
MT
06/07INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Insulet
MT
06/03INSIDER TRENDS : Insulet Sees 90 Days of Insider Buying Trend Slowing with Share..
MT
06/01INSULET CORPá : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/25INSULETá : Barclays Starts Insulet at Overweight with $300 Price Target
MT
05/14INSIDER TRENDS : Insider Sale at Insulet Scaling Back 90-Days of Buying
MT
05/14INSULET CORPá : Unregistered Sale of Equity Securities (form 8-K)
AQ
05/07INSULETá : Berenberg Bank Adjusts Insulet PT to $250 From $266, Maintains Hold R..
MT
05/07INSULETá : SVB Leerink Adjusts Insulet PT to $300 From $320, Maintains Outperfor..
MT
05/07INSULETá : Piper Sandler Adjusts Insulet's Price Target to $250 From $260, Maint..
MT
05/07INSULETá : Raymond James Adjusts Insulet's Price Target to $285 From $296, Keeps..
MT
05/07INSULETá : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/06INSULETá : Swings to Break-Even in Q1 from Loss Amid Higher Revenue, Sets Guidan..
MT
05/06INSULET CORPá : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/06INSULET : Q1 Earnings Snapshot
AQ
More news
News in other languages on INSULET CORPORATION
05/26Ventes en progression mais bénéfice annuel divisé par deux pour Ypsomed
05/26Ventes en progression mais bénéfice divisé par deux pour Ypsomed
05/26Ypsomed steigert Umsatz, schreibt aber weniger Gewinn
01/18INSULETá : Le systèmeáOmnipodáDASH« d'Insulet est maintenant offert au Canada
01/04Bourse Zurich: de peu dans le vert pour la première séance de l'année
More news
Analyst Recommendations on INSULET CORPORATION
More recommendations
Chart INSULET CORPORATION
Duration : Period :
Insulet Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INSULET CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 278,84 $
Last Close Price 282,45 $
Spread / Highest target 14,4%
Spread / Average Target -1,28%
Spread / Lowest Target -32,7%
EPS Revisions
Managers and Directors
NameTitle
Shacey Petrovic President, Chief Executive Officer & Director
Wayde Dwight McMillan Chief Financial Officer, Treasurer & Executive VP
Timothy J. Scannell Independent Chairman
Trang Ly Senior Vice President & Medical Director
Charles Alpuche Chief Operations Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
INSULET CORPORATION10.49%18 718
ABBOTT LABORATORIES0.38%195 290
MEDTRONIC PLC5.67%166 534
BECTON, DICKINSON AND COMPANY-3.03%70 564
ALIGN TECHNOLOGY, INC.14.44%48 395
HOYA CORPORATION-2.59%46 812